{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:41:46Z","timestamp":1786372906962,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.2215\/cjn.04540709","type":"journal-article","created":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T21:26:00Z","timestamp":1255641960000},"page":"1993-1997","source":"Crossref","is-referenced-by-count":111,"title":["Acute Hemolysis After High-Dose Intravenous Immunoglobulin Therapy in Highly HLA Sensitized Patients"],"prefix":"10.2215","volume":"4","author":[{"given":"Joseph","family":"Kahwaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Pepkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Villicana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley C.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley A.","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20230601","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1182\/blood.V82.12.3789.3789","article-title":"Hemolysis after high-dose intravenous Ig","volume":"82","author":"Thomas","year":"1993","journal-title":"Blood"},{"key":"R2-21-20230601","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2146\/ajhp070582","article-title":"Unlabeled uses of intravenous immune globulin","volume":"65","author":"Leong","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"R3-21-20230601","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1196\/annals.1423.054","article-title":"Intravenous immunoglobulin and autoimmune disease","volume":"1110","author":"El-Shanawany","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R4-21-20230601","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7861\/clinmedicine.6-4-356","article-title":"Current clinical uses of intravenous immunoglobulin","volume":"6","author":"El-Shanawany","year":"2006","journal-title":"Clin Med"},{"key":"R5-21-20230601","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ncpneph0609","article-title":"Parvovirus-B-19-associated complications in renal transplant recipients","volume":"3","author":"Waldman","year":"2007","journal-title":"Nat Clin Prac Neph"},{"key":"R6-21-20230601","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.tp.0000181096.14257.c2","article-title":"Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: One-year follow-up of renal allograft recipients","volume":"81","author":"Sener","year":"2009","journal-title":"Transplantation"},{"key":"R7-21-20230601","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0887-7963(03)00038-5","article-title":"Risks associated with the use of intravenous immunoglobulin","volume":"17","author":"Pierce","year":"2003","journal-title":"Transfusion Med Rev"},{"key":"R8-21-20230601","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2215\/CJN.01701105","article-title":"Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single center experience","volume":"1","author":"Vo","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-21-20230601","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: Report of the NIH IG02 trial","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R10-21-20230601","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9343(87)90112-4","article-title":"Hemolytic anemia following intravenous gamma globulin administration","volume":"82","author":"Brox","year":"1987","journal-title":"Am J Med"},{"key":"R11-21-20230601","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1537-2995.2008.01721.x","article-title":"Hemolytic transfusion reactions after administraton of intravenous immune (gamma) globulin: A case series analysis","volume":"48","author":"Daw","year":"2008","journal-title":"Transfusion"},{"key":"R12-21-20230601","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/(SICI)1097-4598(199709)20:9<1142::AID-MUS8>3.0.CO;2-8","article-title":"Hemolytic anemia associated with intravenous immunoglobulin","volume":"20","author":"Wilson","year":"1997","journal-title":"Muscle Nerve"},{"key":"R13-21-20230601","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.bbmt.2006.03.003","article-title":"Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG)","volume":"12","author":"Coghill","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"R14-21-20230601","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3476(05)81964-X","article-title":"Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease","volume":"120","author":"Comenzo","year":"1992","journal-title":"J Pediatr"},{"key":"R15-21-20230601","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ajh.21263","article-title":"Hemolytic anemia following intravenous immunoglobulin administration","volume":"83","author":"Yin","year":"2008","journal-title":"Am J Hematol"},{"key":"R17-21-20230601","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"key":"R18-21-20230601","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2215\/CJN.05321107","article-title":"Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies","volume":"3","author":"Akalin","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R19-21-20230601","first-page":"713","article-title":"Overview of renal transplantation","volume":"98","author":"Hashmi","year":"2007","journal-title":"Minerva Med"},{"key":"R20-21-20230601","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1423-0410.1999.7710033.x","article-title":"Isoantibodies in immunoglobulin for intravenous use may cause erythrocyte sequestration:","volume":"77","author":"Shoham-Kessary","year":"1999","journal-title":"Vox Sang"},{"key":"R21-21-20230601","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2249.1998.00624.x","article-title":"Immune complex-like moieties in immunoglobulin for intravenous use (i.v.Ig) bind complement and enhance phagocytosis of human erythrocytes","volume":"113","author":"Shoham-Kessary","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"R22-21-20230601","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2215\/CJN.02750707","article-title":"Inflammatory marker mania in chronic kidney disease: Pentraxins at the crossroad of universal soldiers of inflammation","volume":"2","author":"Kalantar-Zadeh","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-21-20230601","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00467-008-1046-0","article-title":"Inflammation in chronic kidney disease: Role in the progression of renal and cardiovascular disease","volume":"24","author":"Silverstein","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R24-21-20230601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CNP68001","article-title":"Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: Sources and consequences","volume":"68","author":"Yilmaz","year":"2007","journal-title":"Clin Nephrol"},{"key":"R25-21-20230601","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0609.1985.tb00767.x","article-title":"Lack of efficacy of high-dose intravenous immunogloblulin in autoimmune haemolytic anaemia: A clue to its mechanism","volume":"34","author":"Mueller-Eckhardt","year":"1985","journal-title":"Scan J Haematol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-200912000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:39:04Z","timestamp":1786369144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-200912000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.04540709","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}